cerebrospinal fluid And NotBertrand R. Huber

List of bibliographic references

Number of relevant bibliographic references: 9.

Ident.	Authors (with country if any)	Title
000371	M. B. Aerts [Pays-Bas] ; R. A. J. Esselink [Pays-Bas] ; B. R. Bloem [Pays-Bas] ; M. M. Verbeek [Pays-Bas]	Cerebrospinal fluid tau and phosphorylated tau protein are elevated in corticobasal syndrome
000529	E. Wang [République populaire de Chine] ; Y. Sun [République populaire de Chine] ; J. Guo [République populaire de Chine] ; X. Gao [République populaire de Chine] ; J. Hu [République populaire de Chine] ; L. Zhou [République populaire de Chine] ; J. Hu [République populaire de Chine] ; C. Jiang [République populaire de Chine]	Tetranectin and apolipoprotein A‐I in cerebrospinal fluid as potential biomarkers for Parkinson’s disease
000784	K. Ishibashi [Japon] ; K. Kanemaru [Japon] ; Y. Saito [Japon] ; S. Murayama [Japon] ; K. Oda [Japon] ; K. Ishiwata [Japon] ; H. Mizusawa [Japon] ; K. Ishii [Japon]	Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson’s disease
000793	Matteo Marti [Italie] ; Silvio Sarubbo [Italie] ; Francesco Latini [Italie] ; Michele Cavallo [Italie] ; Roberto Eleopra [Italie] ; Sara Biguzzi [Italie] ; Christian Lettieri [Italie] ; Carlo Conti [Italie] ; Michele Simonato [Italie] ; Silvia Zucchini [Italie] ; Rocco Quatrale [Italie] ; Mariachiara Sensi [Italie] ; Sanzio Candeletti [Italie] ; Patrizia Romualdi [Italie] ; Michele Morari [Italie]	Brain Interstitial Nociceptin/Orphanin FQ Levels are Elevated in Parkinson's Disease
000A20	Brit Mollenhauer [Allemagne] ; Claudia Trenkwalder [Allemagne]	Neurochemical biomarkers in the differential diagnosis of movement disorders
000B45	Yaroslau Compta [Espagne] ; María J. Martí [Espagne] ; Naroa Ibarretxe-Bilbao [Espagne] ; Carme Junqué [Espagne] ; Francesc Valldeoriola [Espagne] ; Esteban Mu Oz [Espagne] ; Mario Ezquerra [Espagne] ; Jose Ríos [Espagne] ; Eduardo Tolosa [Espagne]	Cerebrospinal tau, phospho‐tau, and beta‐amyloid and neuropsychological functions in Parkinson's disease
001740	Andrea Carmine [Suède] ; Silvia Buervenich [Suède] ; Dagmar Galter [Suède] ; Erik G. Jönsson [Suède] ; Göran C. Sedvall [Suède] ; Lars Farde [Suède] ; J. Petter Gustavsson [Suède] ; Hans Bergman [Suède] ; Kodavali V. Chowdari [États-Unis] ; Vishwajit L. Nimgaonkar [États-Unis] ; Maria Anvret [Suède] ; Olof Sydow [Suède] ; Lars Olson [Suède]	NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits
001B80	Mari G Rseth [Norvège] ; Ursula Sonnewald [Norvège] ; Linda R. White [Norvège] ; Marianne R D [Norvège] ; John-Anker Zwart [Norvège] ; Ystein Nygaard [Norvège] ; Jan Aasly [Norvège]	Proton magnetic resonance spectroscopy of cerebrospinal fluid in neurodegenerative disease: Indication of glial energy impairment in Huntington chorea, but not Parkinson disease
002981	Merle Ruberg [France] ; François Rieger [France] ; Albert Villageois [France] ; Anne Marie Bonnet ; Yves Agid [France]	Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024